Tag: orforglipron
Orforglipron Shows Clinically Significant HbA1c Reductions in Type 2 Diabetes
Two phase III randomised controlled trials presented at the American Diabetes Association conference in June 2026 demonstrate that orforglipron, a…
Submit Your Paper to GMJ
No APC until January 2027.